Analysis

The corporate evolution from Diffusion Pharmaceuticals to its successor, CervoMed, is now complete. This strategic shift moves the company's valuation...

While Barrick Gold's latest financial results paint a picture of robust health, a significant strategic hurdle has emerged. The mining...

Graphite One Inc. has moved to secure new funding, but the market's immediate reaction has been negative. The Vancouver-based company...

Ekso Bionics Holdings is entering what could be a transformative first half of 2026. The company stands at a critical...

Metaplanet has issued a clarification regarding a recently announced financing round. The company's Chief Executive, Simon Gerovich, has publicly reaffirmed...

Shares of video game publisher Take-Two Interactive have faced considerable selling pressure recently, weighed down by sector-wide concerns and emerging...

While Flushing Financial has released its full-year results, the investment community's primary focus remains fixed on its pending merger with...

As of February 2026, the two biotech pioneers synonymous with the mRNA-based COVID-19 vaccine rollout, Moderna and BioNTech, face a...

Eli Lilly & Company is currently benefiting from two significant and concurrent developments that bolster its business outlook. These events...

Investors in Uranium Energy Corp. (UEC) are watching two significant catalysts: a pivotal shareholder vote at a partner company and...